| (Values in U.S. Thousands) | Jun, 2018 | Jun, 2017 | Jun, 2016 | Jun, 2015 | Jun, 2014 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -1,280 | -20 | -20 | -50 | 0 |
| Net Income Growth | -6,300.32% | unch | +60.00% | unch | unch |
Intiva Biopharma Inc (NTVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
INTIVA BioPharma Inc. is involved in Researchers and Developers of Cannabinoid-Based Pharmaceuticals in accordance with U.S. Food and Drug Administration Pre-Clinical and Clinical Pathways. INTIVA BioPharma Inc., formerly known as Kinder Holding Corp. , is based in Denver, Colorado.